PPMD Community

Ana Vaish's Page

Latest Activity

Char Burke and Ana Vaish are now friends
Apr 16, 2011
Ana Vaish replied to Char Burke's discussion Going to Cincinnati to see Dr. Wong and company
"We will be there April 19-22. Our son is also 8 yrs old. Hope to see u there."
Apr 16, 2011
Ana Vaish replied to RAKTIM SINGH's discussion Results of Prosensa’s Extended Phase I/II Exon-skipping Trial in Duchenne Muscular Dystrophy Published in the New England Journal of Medicine
"What about the protein found in the urine? Isn't that going to cause problems in the kidney knowing this will be a life long treatment........"
Mar 24, 2011
Ana Vaish joined Bains's group
Thumbnail

India

For folks to share information about any research happening in India for Duchenne.
May 9, 2010
Ana Vaish is attending Deb Robins's event
Thumbnail

Online Chat with Annemieka Aartsma-Rus Part 2 at Amsterdam to the world

January 9, 2010 from 9:30pm to 10:30pm
Part 2 "Overview of genetic approaches for Duchenne muscular dystrophy" Chat online with Dutch scientist Annemieka Aartsma-Rus giving us lucid explanations of genetic research and question time. Part 1 focused on exon-skipping but Part 2 will focus on the other approaches. Of course times vary – please use one of the following cities as a guide to working out your local time or check World Time. Amsterdam:…See More
Dec 22, 2009
Ana Vaish is attending Deb Robins's event
Thumbnail

Annemieka Aartsma-Russ on Exon Skipping [Online Chat Oct 4] at Duchenne Foundation Live Online Conference Room

October 4, 2009 from 8pm to 9pm
Annemieka Aartsma-Rus (The Netherlands) presents Live Online Chat Oct 4th AEST 8 PM “Exon skipping for Duchenne Muscular Dystrophy” Annemieke Aartsma-Rus will explain the rationale of the exon skipping therapy, will give an update of the current state of affairs on exon skipping clinical trials and will cover some frequently asked questions. Afterwards…See More
Sep 20, 2009
Ana Vaish joined Roxanne's group
Thumbnail

In-frame Mutations with DMD Phenotype/Outliners

The reading frame rule holds true 90% of the time. There remains those 10% that does not fit dmd/bmd phenotype. There is a 3rd form that may be considered as an intermediate between Duchenne and Becker MD(mild DMD or severe BMD.See More
May 27, 2009
Ana Vaish joined MicahsDaddy's group
Thumbnail

Medication/Supplement Journals

A place to keep a journal of what medication(s)/supplement(s) you are giving to your child.See More
Apr 14, 2009

Profile Information

Name(s) of child(ren)/individual(s) with Duchenne:
Ryan
Age(s) of child(ren)/individual(s) with Duchenne:
4-6
City:
Arcadia, Ca

Comment Wall (32 comments)

You need to be a member of PPMD Community to add comments!

Join PPMD Community

At 8:39am on February 6, 2011, Lori Ware said…

Hi Ana,

 

there are several options:

www.miracleflights.org

or through continental - email malia reed at careforce@embarqmail.com (this is how you request a flight through continental's program called Careforce)

or private planes:  maybe angel flight..if close enough or a group called Wings of Hope (google either one of these).  I have flown all except Angel flight. Wings of hope is a small private plane.  all of these will fly one patient and one parent...

Good luck!

At 2:40pm on December 4, 2009, Ofelia Marin said…
Thank you so much! My son is too young to participate but I love to see things progressing!
At 4:19pm on December 3, 2009, Ofelia Marin said…
Good. Just wanted to make sure that you know. Did she say when they expect the trial to start? Any other info about how exon skipping works so far? Does she think that this will be approved in 2-3 years?
At 4:07pm on December 3, 2009, Ofelia Marin said…
Hi Ana,

I hope all is well.
Please take a look at the latest discussion about the exon skipping trial. Someone posted that Dr. Wong told her that they are a site for the Prosensa trial. I think you emailed her a couple of months ago to ask, but I remember she said no at the time (??). So you might want to ask Michelle about it.

Ofelia
At 8:24am on October 4, 2009, Deb Robins said…
About the comment under mine, in Annemieka's last paper or it might have been tonight, she talks about there being a few different variables between the studies and so I agree they could be very similar in outcome until all conditions are made identical.
At 8:17am on October 4, 2009, Deb Robins said…
Hi Ana, I'm sorry I didn't check with DMD community while the chat was ongoing. I didn't think to. When you say you couldn't connect, have any attempts to open the conference room URL worked for you?
http://www.hotconference.com/conference,49190604
What web browser are you running? Internet Explorer? I was unable to record the chat as well, I was booted a couple of times from the room and that lost the recordings I had initiated. Other than that we heard Annemieka well and saw her presentation and her face. I don't think the dozen others got booted out as much as I did. I am only learning and will make sure I check this next time. We had a practice chat last two nights leading up to tonight. Let me know if the room doesn't work when you try it in next couple of days and your OS and I'll ask the software people?
At 2:59pm on September 29, 2009, Ofelia Marin said…
Hi Ana,

I do not know if it will be safety only. My impression is that it will not be safety ONLY since the AVI ceo says that they plan to use the dose levels found working in the UK trial.

People say that AVI's chemistry is "better" than Prosensa's but if you look at the comparison b/w % dystrophin in the intramuscular trials they seem to be performing the same. What's important is what % is obtained in the systemic trials. Prosensa does not say how much dystrophin they obtained and AVI will let us know end of year...then we can have a better idea if one is better than the other.

Got to run. Talk to u soon.
At 6:27pm on September 24, 2009, irishgirl said…
Thanks Ana: I did fin out some information.
I just got this email in from the Ohio folks where the AVI trial is slated to take place.
Hello,

You contacted Lindsay Arnott who used to work in our institution, back in April and she had a chart open for your child. We have his name, date of birth and mutation and he is included in our list of potential candidates.
However, we are not ready to start the trial yet. The sponsor, AVI, will give his “go”, hopefully in a few months, and we will start enrolling patients. We will contact at this time to proceed to enrollment and screening. We would be very happy to have Liam in the trial and we will make sure to contact you back.
In the meantime, if you have questions about the trial, please feel free to email me.
Thank you very much.
Best regards,

Laurence

Laurence Viollet, PhD
Clinical Research Coordinator
Team Project Leader
Center for Gene Therapy
The Research Institute at Nationwide Children's Hospital
700 Children's Drive
Columbus, OH 43205
Phone: (614) 355-2695
Fax: (614) 355-5247
Laurence.Viollet@nationwidechildrens.org
At 1:52pm on September 24, 2009, irishgirl said…
What's this EMEA/FDA meeting in london this weekend? I know nothing about it - just the conference in London in October. Do you have a link???
Thanks
At 1:45pm on September 24, 2009, irishgirl said…
Yippie!
Dr. Leshner is really excited about the hoopla here!!!!!
 
 
 

© 2014   Created by PPMD.

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service